NM_000492.4:c.509G>A
Variant summary
The NM_000492.4(CFTR):c.509G>A (p.Arg170His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene CFTR is a tumor suppressor gene (CancerMine: 18 TSG, 1 driver citations). The gene CFTR is a cancer driver gene (CancerMine: 18 TSG, 1 driver citations). The variant allele was found at a cumulative frequency of 0.000514 (AC=819) in the gnomAD database across 1,593,672 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000431. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (no review stars). ClinVar reports functional evidence for this variant: "SCV001477556: Functional analyses of the variant show a slight increase in exon 5 skipping (Aissat 2013), but mature protein expression levels and chloride transport activity similar to wildtype (LaRusch 2014). However, the variant protein exhibits impaired bicarbonate transport, which is also observed for other CFTR variants enriched in pancreatitis patients (LaRusch 2014). PMID:25033378". Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R170C: Uncertain_significance (ClinVar VariationId 455782, 2 stars); p.R170= (synonymous): Likely_benign (ClinVar VariationId 695287, 2 stars); p.R170S: Uncertain_significance (ClinVar VariationId 1053721, 2 stars) The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.). This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital bilateral aplasia of vas deferens from CFTR mutationInheritance: AR Classification: DEFINITIVE Submitted by: Natera
- cystic fibrosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Myriad Women's Health, ClinGen, Natera, Orphanet
- congenital bilateral absence of vas deferensInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary chronic pancreatitisInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 3 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 9 pathogenic, 0 benign (OR vs. background: 95.0); Variant does not impact splicing — splice-hotspot path not applicable | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: -1.07 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000492.4. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CFTR | TSL:1MANE Select | c.509G>A p.Arg170His | missense | Exon 5 of 27 | Prot: ENSP00000003084.6 UniProt: | |
CFTR | c.509G>A p.Arg170His | missense | Exon 5 of 27 | Prot: ENSP00000514471.1 UniProt: | ||
CFTR | c.509G>A p.Arg170His | missense | Exon 5 of 26 | Prot: ENSP00000559265.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.000434 | AC:66 | Hom:0 | AN:152002 | Cov:33 |
GnomAD2 exomes | AF: 0.000499 | AC:125 | AN:250408 | ||
GnomAD4 exome | AF: 0.000522 | AC:752 | Hom:0 | AN:1441552 | Cov:26 |
GnomAD4 genome | AF: 0.000440 | AC:67 | Hom:0 | AN:152120 | Cov:33 |
TOPMed (Bravo) | AF: 0.000502 | AC:133 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.000506 | AC:268 | Hom:0 | AN:529980 | |
Local & regional cohorts 6 sources | |||||
ChinaMAP Phase 1 | AF: 0.000246 | ||||
ESP6500 (Exome Variant Server) | AF: 0.000615 | AC:8 | AN:13002 | ||
GenomeAsia100K | AF: 0.000289 | AC:1 | AN:3478 | ||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.0000160 | AC:2 | Hom:0 | AN:122488 | |
Turkish Variome | AF: 0.000605 | AC:4 | Hom:0 | AN:6610 | |
UK10K | AF: 0.000264 | AC:2 | AN:7562 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.000422 * | 4 | 9484 | 0.000388 * | 4 | 10308 |
BipEx | 0.000388 | 11 | 28384 | 0.000208 | 6 | 28794 |
Epi25 | 0.000406 | 17 | 41884 | 0.000643 | 43 | 66834 |
SCHEMA | 0.000485 | 59 | 121634 | 0.000462 | 88 | 190460 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 23 | |
AlphaMissense | Benign | 0.16 | |
BayesDel_addAF | Pathogenic | 0.19 | D |
BayesDel_noAF | Pathogenic | 0.34 | |
CADD | Pathogenic | 33 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Uncertain | 0.68 | D |
Eigen | Pathogenic | 0.78 | |
Eigen_PC | Pathogenic | 0.78 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
GPN-Star LLR | N/A | -7.4 | |
GPN-Star score | N/A | 7.4 | |
LIST_S2 | Pathogenic | 0.98 | D |
M_CAP | Pathogenic | 0.83 | D |
MetaRNN | Benign | 0.031 | T |
MetaSVM | Uncertain | 0.70 | D |
Mutation Taster | N/A | 6/94 | disease causing (ClinVar) |
MutationAssessor | Benign | 1.9 | L |
PhyloP100 | Uncertain | 7.1 | |
popEVE | Benign | -3.3 | |
PrimateAI | Uncertain | 0.76 | T |
PROVEAN | Benign | -1.7 | N |
REVEL | Pathogenic | 0.83 | |
Sift | Uncertain | 0.0070 | D |
Sift4G | Pathogenic | 0.0010 | D |
Varity_R | N/A | 0.44 | |
VESM-3B | Benign | -5.8 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.030 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Splicevardb | N/A | 2.0 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.